WASHINGTON — The White House is pitching an added benefit to Democrats’ recent drug pricing reform package: lower cancer death rates.
A new analysis by the Council of Economic Advisers focused on the new law capping Medicare patients’ out-of-pocket costs for pharmacy drugs at $2,000 per year, starting in 2025. Over 449,000 current Medicare enrollees with a prior cancer diagnosis would save an average of nearly $1,600 per year on prescription drugs because of the out-of-pocket cap. Right now, there’s no limit on patients’ out-of-pocket costs.
The White House is framing the law as a boon to President Biden’s Cancer Moonshot, which aims to reduce the death rate from cancer by at least 50% over the next 25 years. If patients can afford drugs that they couldn’t otherwise, then that could extend patients’ lives, said White House Cancer Moonshot Coordinator Danielle Carnival.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
